Entegris Defends Deal With Versum After Merck Bid
27 Febbraio 2019 - 9:24PM
Dow Jones News
By Micah Maidenberg
Chemicals and materials company Entegris Inc. (ENTG) defended
its proposed merger with Versum Materials Inc. (VSM).
Earlier on Wednesday, German pharmaceutical and chemical company
Merck KGaA (MRK.XE) offered to buy Versum for $48 a share in cash,
giving the proposed deal an equity value of about $5.2 billion.
Versum said it would review the offer.
Entegris Chief Executive Bertrand Loy said Wednesday afternoon
the planned merger with Versum would provide value to shareholders
by bringing together two complementary companies.
"The all-stock merger of equals of Entegris and Versum Materials
will create a premier specialty materials company for the
semiconductor and other high-tech industries and will be able to
deliver meaningful value to Versum Materials and Entegris
stockholders," Mr. Loy said in prepared remarks.
Write to Micah Maidenberg at micah.maidenberg@wsj.com
(END) Dow Jones Newswires
February 27, 2019 15:09 ET (20:09 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Grafico Azioni Versum Materials (NYSE:VSM)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Versum Materials (NYSE:VSM)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Versum Materials Inc (Borsa di New York (NYSE)): 0 articoli recenti
Più Versum Materials, Inc. Articoli Notizie